¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÆó¾ÏÇÐȸ (¿Â¶óÀÎ) 2021 KALC International Conference (2ÀÏÂ÷) : 2021-11-26

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÆó¾ÏÇÐȸ (¿Â¶óÀÎ) 2021 KALC International Conference (2ÀÏÂ÷) : 2021-11-26
±³À°ÀÏÀÚ : 2021-11-26
±³À°Àå¼Ò : ¿Â¶óÀÎ Çмú´ëȸ  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021 KALC International Conference (2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÆó¾ÏÇÐȸ
´ã´çÀÚ : ±èÀÎÁ¤
¿¬¶ôó : 02-741-8540  
À̸ÞÀÏ : kalc@lungca.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú      
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 70,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ08:00~08:50 Overcoming Resistance to Immune-Targeted Therapies  Fabrice Barlesi(Gustave Roussy France) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ08:50~09:10 Radial EBUS Guided TBLB for Peripheral Pulmonary Lesions  June Hong Ahn(Yeungnam Univ.) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ09:10~09:30 ENB-Guided Preoperative Localization for Small Pulmonary Nodules  In Kyu Park(Seoul National Univ.) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ09:30~09:50 ENB-Guided Ablative Therapy  Calvin S. H. Ng(The Chinese Univ. of Hong Kong Hong Kong) 
È޽Ġ11-26 ¿Â¶óÀΠ09:50~10:10   () 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ10:10~10:35 How to Handle Oligometastatic Disease in Non-Small Cell Lung Cancer  Hauke Winter(Universitätsklinikum Heidelberg Germany) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ10:35~11:00 Surgical Role in Oligometastasis to Spines  Seung-Jae Hyun(Seoul National Univ.) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ11:00~11:25 Local Ablative Therapy with Radiation in Extra-Thoracic Visceral Oligometastasis  Jin Ho Kim(Seoul National Univ.) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ11:25~12:10 Lorlatinib: Clinical Data and Implications for the Sequential Therapy in Anaplastic Lymphoma Kinase+ Non-Small Cell Lung Cancer  Benjamin J Solomon(Peter MacCallum Cancer Centre Australia) 
½Ä»ç 11-26 ¿Â¶óÀΠ12:10~13:00   () 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ13:00~13:25 Oligometastasis with Radiotherapy and Immunotherapy  Ralph Weichselbaum(The University of Chicago Medicine USA) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ13:25~13:50 T Cell Metabolism and CAR-T  Hongbo Chi(St. Jude Children) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ13:50~14:15 Cold to Hot Conversion  In-San Kim(KIST) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ14:15~14:40 How Can We Enhance the Treatment Responses of Anti-PD-1 in Cancers?  Su-Hyung Park(KAIST) 
È޽Ġ11-26 ¿Â¶óÀΠ14:40~15:00   () 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ15:00~15:25 Predictive Biomarkers to Immune Checkpoint Blockade  Hye Ryun Kim(Yonsei Univ) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ15:25~15:50 Resistance Mechanisms to Immune Checkpoint Blockade  Se-Hoon Lee(Sungkyunkwan Univ.) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ15:50~16:15 Novel Immune Checkpoint Blockade  Se Hoon Park(Sungkyunkwan Univ.) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ16:15~16:40 Immunotherapy Beyond Immune Checkpoint Blockade  Ross Soo(National Univ. Cancer Institute Singapore) 
È޽Ġ11-26 ¿Â¶óÀΠ16:40~16:50   () 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ16:50~17:40 Shifting Paradigm in EGFRm Non-Small Cell Lung Cancer Treatment from Early to Advance Stage Patients  Helena A. Yu(MSKCC USA) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÆó¾ÏÇÐȸ (¿Â¶óÀÎ) 2021 KALC International Conference (2ÀÏÂ÷) : 2021-11-26""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2021 ´ëÇѳúÀüÁõÇÐȸ 11¿ù °³¿øÀÇ ¿¬¼ö°­Á : 2021-11-28
´ÙÀ½±Û °ø°øÀÇ·á´Â °ø°øº´¿ø¸¸ÀÇ Àǹ«ÀÌ°í ¿ªÇÒÀΰ¡? ±× ³íÀï¿¡ ´ëÇÏ¿© : 2021-11-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21135 °æ±â Á¦10Â÷ ¿¬¼¼ÀÇ´ë ¼Ò¾Æû¼Ò³â°ú Áö¿ªÀÇ»ç Áý´ãȸ : 2024-07-31 0 41 2024-06-19
21134 °æ±â 2024 Çѱ¹¼ö¸éÇÐȸ ÇÏ°èÇмú´ëȸ : 2024-07-26 0 49 2024-06-19
21133 ¼­¿ï 2024³â ´ëÇÑÇǺη¹ÀÌÀúÇÐȸ Á¦25ȸ Çмú´ëȸ : 2024-07-21 0 41 2024-06-19
21132 ¼­¿ï ´ëÇÑÀÓ»ó¾Ï´ë»çÀÇÇÐȸ 2024³â Ãß°èÇмú´ëȸ IVC¿Í Detox : 2024-07-21 0 36 2024-06-19
21131 ´ë±¸ ´ë±¸°æºÏ³»°úÇÐȸ 2024³â Á¤±âÇмú´ëȸ : 2024-07-21 0 35 2024-06-19
21130 Á¦ÁÖ Á¦13ȸ ´ëÇѳ»ºÐºñÇÐȸ Á¦ÁÖÁöȸ ¿¬¼ö°­Á : 2024-07-20 0 24 2024-06-19
21129 ±¤ÁÖ Á¦225Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ ±¤ÁÖÀü³²Áöȸ ¿¬¼ö°­Á : 2024-07-16 0 24 2024-06-19
21128 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦3ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-07-15 0 43 2024-06-19
21127 ¼­¿ï 2024 ¼¼ºê¶õ½ºº´¿ø ¼ÒÈ­±âÇÐ ¿¬¼ö°­Á : 2024-07-14 0 39 2024-06-19
21126 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑôÃß¿µ»óÀÇÇÐȸ Á¤±â¿¬¼ö°­Á : 2024-07-14 0 34 2024-06-19
21125 ¼­¿ï Á¦29Â÷ Ưº°¿¬¼ö°­Á – »êºÎÀΰú Áúȯ óġÀÇ ÃֽŠÁö°ß : 2024-07-14 0 26 2024-06-19
21124 °­¿ø 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °­¿øÁöȸ ¿¬¼ö°­Á : 2024-07-14 0 30 2024-06-19
21123 ¼­¿ï 2024³â ´ëÇѹ̼¼¼ö¼úÇÐȸ Ãá°è ¹Ì¼¼¼ö¼ú ¿öÅ©¼ó : 2024-07-14 0 28 2024-06-19
21122 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(2ÀÏÂ÷) : 2024-07-14 0 27 2024-06-19
21121 ¼­¿ï Á¦8ȸ ÀüÀÓÀÇ Àü°øÀÇ °³¿øÀǸ¦ À§ÇÑ °£Áúȯ ¿¬¼ö°­Á : 2024-07-14 0 49 2024-06-19
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷